Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Samuel Zachary Goldhaber, M.D.


This page shows the publications co-authored by Samuel Goldhaber and Anthony D'Amico.
Connection Strength

  1. Coronary artery revascularization and the risk of death in men with prostate cancer. J Urol. 2011 Sep; 186(3):898-902.
    View in: PubMed
    Score: 0.488
  2. Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries. Harv Heart Lett. 2010 Jul; 20(11):8.
    View in: PubMed
    Score: 0.454
  3. Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis. Cancer. 2013 May 15; 119(10):1808-15.
    View in: PubMed
    Score: 0.136
  4. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation. Cancer. 2011 Jan 15; 117(2):406-13.
    View in: PubMed
    Score: 0.115
  5. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007 Jun 10; 25(17):2420-5.
    View in: PubMed
    Score: 0.092
  6. Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. J Natl Cancer Inst. 2017 06; 109(6).
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.